RE104 for Injection

DRUG4 trials

Sponsors

Reunion Neuroscience Inc

Conditions

Adjustment DisorderGeneralized Anxiety DisorderLactationPostpartum Depression

Phase 1

RE104 Clinical Lactation Study

CompletedNCT06659263

Reunion Neuroscience IncLactation

Start: 2024-11-13End: 2025-06-04Updated: 2025-06-12

Phase 2

RE104 Safety and Efficacy Study in Postpartum Depression

CompletedNCT06342310

Reunion Neuroscience IncPostpartum Depression

Start: 2024-06-14End: 2025-06-16Updated: 2026-05-14

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

RecruitingNCT07002034

Reunion Neuroscience IncAdjustment Disorder

Start: 2025-07-30End: 2026-12-01Target: 100Updated: 2026-09-15

RE104 Safety and Efficacy Study in Generalized Anxiety Disorder

RecruitingNCT07489651

Reunion Neuroscience IncGeneralized Anxiety Disorder

Start: 2026-04-20End: 2027-04-01Target: 64Updated: 2026-08-18

Related Papers

164. PSILOCYBIN DURING THE POSTPARTUM PERIOD INDUCES LONG-LASTING ADVERSE EFFECTS IN BOTH MOTHERS AND OFFSPRING

The International Journal of Neuropsychopharmacology2025-08-01